May 26 Application Review Subcommittee Meeting

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: May 26, 2022
Time: 9:00 am to 11:00 am
Location: 685 Gateway Blvd., Conf. Rm. B
South San Francisco, CA 94080

 

Due to the expiration of Executive Order N-1-22, which extended the suspension of certain provisions of the Bagley-Keene Open Meeting Act until March 31, 2022 in response to the COVID-19 pandemic, this meeting of the Application Review Subcommittee will be conducted in person and via noticed teleconference locations, which will be made accessible to the public.  Members of the public may attend this meeting in person at the address printed above, at a teleconference location listed below, or remotely via the options listed below.

 

Teleconference Locations

  • 2 Koret Way, #605L, San Francisco, CA 94143-0610
  • 2007 Redwood Rd., Napa, CA 94558
  • 2619 Montclair Street San Diego, CA 92104
  • 1108 Myrtle Street, Calistoga, CA 94515
  • 11440 San Vicente Blvd, Los Angeles, CA 90049
  • 6220 Playa Vista Place, Avila Beach, CA 93424
  • 4005 N Fresno St suite 104 Fresno CA 93726
  • 7656 Sunset Blvd. LA CA 90046
  • 21211 Rainbow Drive, Cupertino CA 95014
  • 10996 Torreyana Rd, Suite 200 | San Diego, CA 92121
  • 810 El Chorro Way, Sacramento, CA 95864
  • 10850 Gold Center Drive Suite 325, Rancho Cordova, CA 95670
  • 2 Crow Hollow Rd., Chapel Hill, NC 27514
  • 5950 Canoga Ave, Suite 110, Woodland Hills CA 91367-5011
  • 44 Dorothy Way, Novato, CA 94945
  • 770 Seale Avenue, Palo Alto, CA  94303
  • 650 Charles E Young Drive South A2-237 CHS MC: 167917, Los Angeles, CA. 90095
  • 278 North 7th Street, San Jose CA 95112

 

 

Public Comment Instructions

Members of the public who are listening to the meeting and wish to make a comment will have the opportunity to do so by doing the following:  

  • Once we have called for public comment, members of the public will be able to do so by pressing *9 which will place you in a queue to make your comment
  • Once we call your name you will have 3 Minutes to make your public comment; please remember to be respectful of the time limit.
  • Written comment may be sent to the following email address: kmccormack@cirm.ca.gov. 
  • Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location.
     

YouTube: www.youtube.com/cirmtv

Dial-In information:
Dial in number: (669) 900-6833
Meeting ID: 880 1069 0657
Passcode: 220526
 

Open Session

  1. Call to Order
     
  2. Roll Call
     

Action Items

  1. Consideration of applications submitted in response to Clinical Trial Stage Projects Program Announcement (CLIN 1 or 2)

Discussion Items

  1. Public comment
     
  2. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 510-340-9111 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 510-340-9111.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

Date Published: May 16, 2022
Last Modified: September 16, 2022